IN2014DN01822A - - Google Patents
Info
- Publication number
- IN2014DN01822A IN2014DN01822A IN1822DEN2014A IN2014DN01822A IN 2014DN01822 A IN2014DN01822 A IN 2014DN01822A IN 1822DEN2014 A IN1822DEN2014 A IN 1822DEN2014A IN 2014DN01822 A IN2014DN01822 A IN 2014DN01822A
- Authority
- IN
- India
- Prior art keywords
- relates
- present
- protease inhibitor
- conjugates
- conjugated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8142—Aspartate protease (E.C. 3.4.23) inhibitors, e.g. HIV protease inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- AIDS & HIV (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1114017.5A GB201114017D0 (en) | 2011-08-15 | 2011-08-15 | Inhibitors against endosomal/ysosomal enzymes |
PCT/GB2012/000660 WO2013024243A1 (en) | 2011-08-15 | 2012-08-15 | Inhibitors against endosomal/lysosomal enzymes |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN01822A true IN2014DN01822A (es) | 2015-05-15 |
Family
ID=44764498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1822DEN2014 IN2014DN01822A (es) | 2011-08-15 | 2012-08-15 |
Country Status (6)
Country | Link |
---|---|
US (1) | US9050374B2 (es) |
EP (1) | EP2744821B1 (es) |
CN (1) | CN103814046B (es) |
GB (1) | GB201114017D0 (es) |
IN (1) | IN2014DN01822A (es) |
WO (1) | WO2013024243A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6907188B2 (ja) * | 2015-08-13 | 2021-07-21 | ダイアックス コーポレーション | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 |
EP3482754B1 (en) | 2016-08-11 | 2020-12-23 | IntraBio Ltd | Pharmaceutical compositions and uses directed to lysosomal storage disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999048910A1 (en) | 1998-03-26 | 1999-09-30 | University Of Dundee | Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |
US7247704B2 (en) * | 2000-12-18 | 2007-07-24 | Arriva Pharmaceuticals, Inc. | Multifunctional protease inhibitors and their use in treatment of disease |
-
2011
- 2011-08-15 GB GBGB1114017.5A patent/GB201114017D0/en not_active Ceased
-
2012
- 2012-08-15 EP EP12753163.0A patent/EP2744821B1/en not_active Not-in-force
- 2012-08-15 IN IN1822DEN2014 patent/IN2014DN01822A/en unknown
- 2012-08-15 WO PCT/GB2012/000660 patent/WO2013024243A1/en active Application Filing
- 2012-08-15 CN CN201280039856.9A patent/CN103814046B/zh not_active Expired - Fee Related
- 2012-08-15 US US14/239,354 patent/US9050374B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2013024243A1 (en) | 2013-02-21 |
EP2744821A1 (en) | 2014-06-25 |
GB201114017D0 (en) | 2011-09-28 |
EP2744821B1 (en) | 2016-12-07 |
CN103814046B (zh) | 2017-05-17 |
US20140308318A1 (en) | 2014-10-16 |
US9050374B2 (en) | 2015-06-09 |
CN103814046A (zh) | 2014-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG195196A1 (en) | Dual targeting | |
EP4223770A3 (en) | Novel fusion molecules and uses thereof | |
MX345514B (es) | Composiciones pesticidas. | |
UA114611C2 (uk) | Пестицидні композиції і способи, що їх стосуються | |
BR112012025645A2 (pt) | glicanos de alta manose. | |
MX340831B (es) | Composiciones pesticidas. | |
BR112013007362A2 (pt) | composição farmacêutica | |
EP2638521A4 (en) | INTAKE OR PRESENCE-BASED TARGETING | |
IL227682A0 (en) | Compounds suppressing 17-il and γ- ifn, preparations containing them and their uses | |
BR112014001219A2 (pt) | perfume | |
UA114655C2 (uk) | Піридин-2-аміди, придатні як агоністи канабіноїдного рецептора 2 | |
GB201103836D0 (en) | Conjugation process | |
EP2632895A4 (en) | HIV PROTEASE INHIBITORS | |
MY161868A (en) | Anti-bv8 antibodies and uses thereof | |
IN2014CN02318A (es) | ||
EP2435037A4 (en) | HIV PROTEASE INHIBITORS | |
UA112760C2 (uk) | Теобромін у комбінації з гвайфенезином для лікування кашлю | |
CL2009001973S1 (es) | Mostrador. | |
WO2014052713A3 (en) | Her2-and vegf-a-binding proteins with enhanced stability | |
IN2014DN01822A (es) | ||
EA201391563A1 (ru) | Твердое вещество полихлоропрен с тиксотропными свойствами | |
HK1151718A1 (en) | Flupentixol compositions | |
BR112013032223A2 (pt) | molécula de ácido nucleico isolada, e, composição | |
PL2306995T3 (pl) | Właściwości przeciwnowotworowe inhibitorów proteazy zmodyfikowanych NO | |
MX2015006616A (es) | Doble direccion. |